TransAct Technologies Completes $9.8 Million Public Offering of Common Stock, Including Full Exercise of Overallotment Option

The proceeds to the Company from the offering were approximately $9.8 million before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.